S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NASDAQ:CASICASI Pharmaceuticals News Headlines

$1.94
+0.03 (+1.57 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.89
Now: $1.94
$2.05
50-Day Range
$1.89
MA: $2.20
$2.58
52-Week Range
$1.15
Now: $1.94
$3.82
Volume766,711 shs
Average Volume306,509 shs
Market Capitalization$234.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.91

Headlines

CASI Pharmaceuticals (NASDAQ CASI) News Headlines

Source:
DateHeadline
CASI Pharmaceuticals Inc (CASI) Q2 2020 Earnings Call TranscriptCASI Pharmaceuticals Inc (CASI) Q2 2020 Earnings Call Transcript
fool.com - August 11 at 11:37 AM
CASI Pharmaceuticals (NASDAQ:CASI) Announces Quarterly  Earnings Results, Beats Expectations By $0.01 EPSCASI Pharmaceuticals (NASDAQ:CASI) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS
americanbankingnews.com - August 11 at 11:09 AM
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2020 Results - Earnings Call TranscriptCASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 12:44 AM
CASI Pharmaceuticals EPS misses by $0.01, misses on revenueCASI Pharmaceuticals EPS misses by $0.01, misses on revenue
seekingalpha.com - August 10 at 9:41 AM
CASI Pharmaceuticals: Q2 Earnings InsightsCASI Pharmaceuticals: Q2 Earnings Insights
benzinga.com - August 10 at 9:41 AM
CASI Pharmaceuticals Announces Second Quarter 2020 Financial ResultsCASI Pharmaceuticals Announces Second Quarter 2020 Financial Results
finance.yahoo.com - August 10 at 9:41 AM
CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal ACASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal A
bloomberg.com - August 6 at 3:23 AM
CASI Pharmaceuticals (CASI) Set to Announce Earnings on MondayCASI Pharmaceuticals (CASI) Set to Announce Earnings on Monday
americanbankingnews.com - August 4 at 11:13 AM
Contrasting CASI Pharmaceuticals (NASDAQ:CASI) & La Jolla Pharmaceutical (NASDAQ:LJPC)Contrasting CASI Pharmaceuticals (NASDAQ:CASI) & La Jolla Pharmaceutical (NASDAQ:LJPC)
americanbankingnews.com - August 4 at 5:53 AM
CASI Pharmaceuticals (NASDAQ:CASI) Shares Gap Up to $2.07CASI Pharmaceuticals (NASDAQ:CASI) Shares Gap Up to $2.07
www.americanbankingnews.com - July 28 at 3:01 PM
CASI Pharmaceuticals (NASDAQ:CASI) Trading 6.7% Higher  Following Insider Buying ActivityCASI Pharmaceuticals (NASDAQ:CASI) Trading 6.7% Higher Following Insider Buying Activity
www.americanbankingnews.com - July 27 at 6:26 PM
CASI Pharmaceuticals Inc (NASDAQ:CASI) President Buys $38,290.70 in StockCASI Pharmaceuticals Inc (NASDAQ:CASI) President Buys $38,290.70 in Stock
www.americanbankingnews.com - July 24 at 6:14 PM
CASI Pharmaceuticals Inc (NASDAQ:CASI) CEO Wei-Wu He Buys 2,952,426 SharesCASI Pharmaceuticals Inc (NASDAQ:CASI) CEO Wei-Wu He Buys 2,952,426 Shares
www.americanbankingnews.com - July 24 at 5:42 PM
CASI Pharmaceuticals (NASDAQ:CASI) Shares Gap Down to $1.90CASI Pharmaceuticals (NASDAQ:CASI) Shares Gap Down to $1.90
www.americanbankingnews.com - July 23 at 3:38 PM
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Down 14.8%CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Down 14.8%
www.americanbankingnews.com - July 22 at 8:08 PM
CASI Pharmaceuticals prices equity offeringCASI Pharmaceuticals prices equity offering
seekingalpha.com - July 22 at 1:45 PM
CASI Pharmaceuticals Announces Pricing Of $38,000,000 Public Offering Of Common StockCASI Pharmaceuticals Announces Pricing Of $38,000,000 Public Offering Of Common Stock
finance.yahoo.com - July 22 at 1:45 PM
The Daily Biotech Pulse: Aurinias Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgicals Q2 BeatThe Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
www.msn.com - July 22 at 8:45 AM
Casi Pharma readies equity offeringCasi Pharma readies equity offering
seekingalpha.com - July 21 at 7:20 PM
CASI Pharma under pressure on public offeringCASI Pharma under pressure on public offering
seekingalpha.com - July 21 at 7:20 PM
CASI Pharmaceuticals Announces Proposed Public Offering Of Common StockCASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock
finance.yahoo.com - July 21 at 7:20 PM
Heres What CASI Pharmaceuticals, Inc.s (NASDAQ:CASI) Shareholder Ownership Structure Looks LikeHere's What CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Shareholder Ownership Structure Looks Like
finance.yahoo.com - July 9 at 10:49 AM
Here's What CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Shareholder Ownership Structure Looks LikeHere's What CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Shareholder Ownership Structure Looks Like
finance.yahoo.com - July 9 at 10:49 AM
CASI PHARMACEUTICALS, INC. (NASDAQ:CASI) Files An 8-K Submission of Matters to a Vote of Security HoldersCASI PHARMACEUTICALS, INC. (NASDAQ:CASI) Files An 8-K Submission of Matters to a Vote of Security Holders
www.marketwatch.com - June 18 at 10:16 AM
BRIEF-Casi Pharmaceuticals Unit Entered Into Loan Agreement With Juventas Cell Therapy LtdBRIEF-Casi Pharmaceuticals Unit Entered Into Loan Agreement With Juventas Cell Therapy Ltd
www.reuters.com - June 17 at 6:10 PM
CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody ProgramCASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody Program
finance.yahoo.com - June 8 at 8:17 AM
CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare ConferenceCASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference
finance.yahoo.com - June 2 at 7:41 AM
Wei-Wu He Is The Chairman & CEO of CASI Pharmaceuticals, Inc. (NASDAQ:CASI) And They Just Picked Up 32% More SharesWei-Wu He Is The Chairman & CEO of CASI Pharmaceuticals, Inc. (NASDAQ:CASI) And They Just Picked Up 32% More Shares
finance.yahoo.com - May 25 at 8:24 AM
Earnings Update: CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Just Reported And Analysts Are Boosting Their EstimatesEarnings Update: CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Just Reported And Analysts Are Boosting Their Estimates
finance.yahoo.com - May 14 at 8:27 AM
Upgrade: Analysts Just Made A Notable Increase To Their CASI Pharmaceuticals, Inc. (NASDAQ:CASI) ForecastsUpgrade: Analysts Just Made A Notable Increase To Their CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Forecasts
finance.yahoo.com - May 12 at 8:55 AM
CASI Pharmaceuticals Announces First Quarter 2020 Financial ResultsCASI Pharmaceuticals Announces First Quarter 2020 Financial Results
finance.yahoo.com - May 11 at 12:41 PM
CASI: A Change in StrategyCASI: A Change in Strategy
finance.yahoo.com - May 8 at 3:38 PM
Ligand (LGND) Beats on Q1 Earnings & Sales, Raises ViewLigand (LGND) Beats on Q1 Earnings & Sales, Raises View
www.nasdaq.com - May 7 at 12:07 PM
Global Sorafenib Market Size 2020: Determined By Manufacturing Summary, Business Profile And Forecast To 2024Global Sorafenib Market Size 2020: Determined By Manufacturing Summary, Business Profile And Forecast To 2024
www.marketwatch.com - April 20 at 8:29 AM
CASI Pharmaceuticals To Present at 2020 Solebury Trout Virtual Investor ConferenceCASI Pharmaceuticals To Present at 2020 Solebury Trout Virtual Investor Conference
finance.yahoo.com - April 7 at 6:03 PM
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analysts Just Slashed This Years EstimatesCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analysts Just Slashed This Year's Estimates
finance.yahoo.com - March 31 at 12:09 PM
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analysts Just Slashed This Year's EstimatesCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analysts Just Slashed This Year's Estimates
finance.yahoo.com - March 31 at 12:09 PM
Insider Buying: The CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Chairman & CEO Just Bought US$1.1m Worth Of SharesInsider Buying: The CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Chairman & CEO Just Bought US$1.1m Worth Of Shares
finance.yahoo.com - March 29 at 6:27 PM
CASI Pharmaceuticals Inc (CASI) Q4 2019 Earnings Call TranscriptCASI Pharmaceuticals Inc (CASI) Q4 2019 Earnings Call Transcript
www.nasdaq.com - March 17 at 9:09 AM
CASI Pharmaceuticals EPS misses by $0.07, misses on revenueCASI Pharmaceuticals EPS misses by $0.07, misses on revenue
seekingalpha.com - March 16 at 8:08 AM
CASI Pharmaceuticals Announces Full Year 2019 Financial ResultsCASI Pharmaceuticals Announces Full Year 2019 Financial Results
finance.yahoo.com - March 16 at 8:08 AM
Hypoxia Market 2020-2026 Future Outlook || Key Players Aileron Therapeutics, CASI Pharmaceuticals, Spotlight Labs,LLCHypoxia Market 2020-2026 Future Outlook || Key Players Aileron Therapeutics, CASI Pharmaceuticals, Spotlight Labs,LLC
www.marketwatch.com - March 2 at 12:38 PM
Did Changing Sentiment Drive CASI Pharmaceuticalss (NASDAQ:CASI) Share Price Down By 47%?Did Changing Sentiment Drive CASI Pharmaceuticals's (NASDAQ:CASI) Share Price Down By 47%?
finance.yahoo.com - March 2 at 7:37 AM
Did Changing Sentiment Drive CASI Pharmaceuticals's (NASDAQ:CASI) Share Price Down By 47%?Did Changing Sentiment Drive CASI Pharmaceuticals's (NASDAQ:CASI) Share Price Down By 47%?
finance.yahoo.com - March 2 at 7:37 AM
Tumor Necrosis Factor Inhibitors Market Growth Outlook Beyond 2020Tumor Necrosis Factor Inhibitors Market Growth Outlook Beyond 2020
www.marketwatch.com - January 30 at 2:15 PM
What You Must Know About CASI Pharmaceuticals, Inc.s (NASDAQ:CASI) Beta ValueWhat You Must Know About CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Beta Value
finance.yahoo.com - January 26 at 11:13 PM
What You Must Know About CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Beta ValueWhat You Must Know About CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Beta Value
finance.yahoo.com - January 26 at 1:09 PM
Tumor Necrosis Factor Alpha Inhibitors Market is Earnings CAGR Of 7.1% by 2023 | MRFRTumor Necrosis Factor Alpha Inhibitors Market is Earnings CAGR Of 7.1% by 2023 | MRFR
www.marketwatch.com - December 24 at 8:40 AM
Have Insiders Been Buying CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Shares?Have Insiders Been Buying CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Shares?
finance.yahoo.com - December 20 at 8:40 AM
CASI Pharmas CD19 CAR-T clinical trial applications OKd in ChinaCASI Pharma's CD19 CAR-T clinical trial applications OK'd in China
seekingalpha.com - December 4 at 9:03 AM
This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.